Literature DB >> 2054256

A tumor necrosis factor binding protein (TNF-BP)-physiological antagonist of TNF.

I Olsson1, U Gullberg, M Lantz, C Peetre.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2054256     DOI: 10.1007/bf02172088

Source DB:  PubMed          Journal:  Biotherapy        ISSN: 0921-299X


× No keyword cloud information.
  5 in total

1.  A radioreceptor assay for TNF alpha-binding proteins.

Authors:  V Miller; K D Muirden
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

2.  Soluble tumour necrosis factor receptors (sTNF-R) and HIV infection: correlation to CD8+ lymphocytes.

Authors:  A Kalinkovich; G Livshits; H Engelmann; N Harpaz; R Burstein; M Kaminsky; D Wallach; Z Bentwich
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

Review 3.  Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection.

Authors:  L H Calabrese; N Zein; D Vassilopoulos
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

Review 4.  Kinetics of tumour necrosis factor-alpha, soluble tumour necrosis factor receptors, interleukin 1-beta and its receptor antagonist during serious infections.

Authors:  M van Deuren
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994       Impact factor: 3.267

5.  The elevation of plasma soluble tumor necrosis factor receptor levels by TNF induction therapy for patients with malignancy.

Authors:  Y Abe; K Kimura; A Horiuchi; Y Watanabe; S Kimura
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.